Previously, we identified an 80 kDa membrane protein (LMP80) that is capable of binding to LPS and lipid A in the presence of LBP and sCD14. LMP80 could also be detected after immuno-coprecipitation of cell membranes with LPS and lipid A, indicating a physical contact of LMP80 and LPS/lipid A. Further analysis and peptide sequencing revealed that LMP80 is identical to CD55 (decay accelerating factor, DAF), a regulatory molecule of the complement cascade. Transfection of LPS-hyporesponsive Chinese hamster ovary (CHO) cells with human CD55 resulted in the translocation of NF-κB upon stimulation with LPS or lipid A. Our results demonstrate a new functional role of CD55 as a molecule able to mediate LPS-induced activation of cells that may be part of a multimeric LPS receptor complex.
References
1.
Beutler B., Cerami A.The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol1989; 7: 625—655.
2.
Dinarello CABiology of interleukin 1. FASEB J1988; 2: 108—115.
3.
Freudenberg MA, Keppler D., Galanos C.Requirement for lipopolysaccharide-responsive macrophages in galactosamineinduced sensitization to endotoxin. Infect Immun1986; 51: 891—895.
4.
Morrison DC, Ryan JLEndotoxins and disease mechanisms. Annu Rev Med1987; 38: 417—432.
5.
Dentener MA, Bazil V., von Asmuth EJU, Ceska M., Buurman WAInvolvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6, and IL-8 release by human monocytes and alveolar macrophages. J Immunol1993; 150: 2885—2891.
6.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
7.
Gegner JA, Ulevitch RJ, Tobias PSLipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem1995; 270: 5320—5326.
8.
Lee J-D., Kravchenko V., Kirkland TN et al. Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA1993; 90: 9930—9934.
9.
Ulevitch RJ, Tobias PSRecognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol1994; 6: 125—130.
10.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
11.
Haziot A., Lin XY, Zhang F., Goyert SMThe induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent. J Immunol1998; 160: 2570—2572.
12.
Ingalls RR, Golenbock DTCD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med1995; 181: 1473—1479.
13.
Schletter J. , Brade H., Brade L. et al. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect Immun1995; 63: 2576—2580.
14.
el Samalouti VT, Schletter J., Brade H. et al. Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies . Eur J Biochem1997; 250: 418—424.
15.
el Samalouti VT , Schletter J., Chyla I. et al. Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55). FEMS Immunol Med Microbiol1999; 23: 259—269.
16.
Kinoshita T., Medof ME, Silber R., Nussenzweig V.Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med1985; 162: 75—92.
17.
Nicholson-Weller A., Wang CEStructure and function of decay accelerating factor CD55. J Lab Clin Med1994; 123: 485—491.
18.
Kuhn HM, Brade L., Appelmelk BJ, Kusumoto S., Rietschel ET, Brade H.Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun1992 ; 60: 2201—2210.
19.
Andrews NC, Faller DVA rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res1991; 19: 2499.
20.
Delude RL, Fenton MJ, Savedra Jr R. et al. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J Biol Chem1994; 269: 22253—22260.
21.
Ingalls RR, Golenbock DTCD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med1995; 181: 1473—1479.
22.
Kirschning CJ, Wesche H, Merrill AT, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med1998; 188: 2091—2097.
23.
Yang RB, Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling [see comments]. Nature1998; 395: 284—288.
Karnauchow TM, Tolson DL, Harrison BA, Altman E., Lublin DM, Dimock K.The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol1996; 70: 5143—5152.
26.
Cinek T., Horejsi V.The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol1992; 149: 2262—2270.
27.
Harder T., Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol1997; 9: 534—542.
28.
Shenoy-Scaria AM, Kwong J., Fujita T., Olszowy MW, Shaw AS, Lublin DMSignal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J Immunol1992 ; 149: 3535—3541.
29.
Simons K., Ikonen E.Functional rafts in cell membranes. Nature1997; 387: 569—572.
30.
Solomon KR, Kurt-Jones EA, Saladino RA et al. Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide . J Clin Invest1998; 102: 2019—2027.
31.
Stefanova I. , Horejsi V.Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules. J Immunol1991; 147: 1587—1592.
32.
Stefanová I. , Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak IDLipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem1993; 268: 20725—20728.
33.
Thomas PM, Samelson LEThe glycophosphatidylinositol-anchored Thy-1 molecule interacts with the p60fyn protein tyrosine kinase in T cells. J Biol Chem1992; 267: 12317—12322.
34.
Horejsi V., Drbal K., Cebecauer M. et al. GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today1999; 20: 356—361.
35.
Davis LS, Patel SS, Atkinson JP, Lipsky PEDecay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol1988; 141: 2246—2252.
36.
Lund-Johansen F., Olweus J., Symington FW et al. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored antigens . Eur J Immunol1993; 23: 2782—2791.
37.
Parolini I. , Sargiacomo M., Lisanti MP, Peschle C.Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood1996; 87: 3783—3794.
38.
Shibuya K., Abe T., Fujita T.Decay-accelerating factor functions as a signal transducing molecule for human monocytes. J Immunol1992; 149: 1758—1762.
39.
Tosello AC, Mary F., Amiot M., Bernard A., Mary D.Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion. J Inflamm1998; 48: 13—27.
40.
Götz A., Orsó E., Rothe G., Schmitz G.Ligand-specific heteromeric CDH-clustering in inflammation. J Endotoxin Res2000; 6; 106.
